NCT01380483View on ClinicalTrials.gov

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2000

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

doxycycline monohydrate

Tablets, 100 mg, single, oral dose

DRUG

doxycycline monohydrate

Capsule, 100 mg, single, oral dose

Trial Locations (1)

Unknown

Anapharm Inc., Sainte-Foy

Sponsors

Collaborators (1)

Anapharm
All Listed Sponsors
collaborator

Anapharm

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT01380483 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter